Best Method for Smoking Cessation
The most effective approach to smoking cessation combines varenicline (1 mg twice daily for 12 weeks) with behavioral counseling, as this combination achieves the highest quit rates compared to all other interventions. 1, 2
Pharmacotherapy: First-Line Agents
Varenicline (Preferred)
- Varenicline is superior to all other pharmacotherapies, with 6-month quit rates of 21.8% compared to bupropion (16.2%), nicotine patch (15.7%), and placebo (9.4%) 1, 2
- Dosing schedule: Start 1 week before quit date with 0.5 mg once daily for days 1-3, then 0.5 mg twice daily for days 4-7, then 1 mg twice daily from day 8 through week 12 3
- For patients who successfully quit at 12 weeks, continue an additional 12 weeks to increase long-term abstinence 3
- Cardiovascular safety is established—no increased cardiovascular risk in patients with heart disease 1
- Common side effect: nausea, which may require management 4
Combination Nicotine Replacement Therapy (Alternative First-Line)
- Use long-acting (patch) PLUS short-acting NRT (gum, lozenge, inhaler, or nasal spray) for breakthrough cravings 1, 4
- Combination NRT is more effective than single NRT products and has equivalent efficacy to bupropion 5, 2
- This approach is particularly useful for highly nicotine-dependent smokers 6
Bupropion SR (Alternative First-Line)
- Standard dose: 150 mg twice daily (maximum 300 mg/day) 5
- Start 1-2 weeks before quit date, beginning with 150 mg once daily for 3 days, then increase to 150 mg twice daily 5
- Continue for 7-12 weeks 5
- Particularly beneficial for patients with comorbid depression 5
- Contraindications: seizure disorders, eating disorders, abrupt alcohol/benzodiazepine discontinuation 5
Behavioral Interventions (Essential Component)
Brief Counseling (Minimum Standard)
- Even 3-minute counseling increases quit rates (relative risk 1.66) 1
- Use the "5 A's" approach: Ask about tobacco use, Advise to quit, Assess willingness, Assist with quit attempt, Arrange follow-up 1
- Clear, personalized, nonjudgmental messages focusing on benefits: "Quitting smoking is the most important thing you can do for your heart health" 1
Intensive Counseling (Optimal)
- Provide at least 4 counseling sessions with trained specialists 1, 4
- Dose-response relationship exists—more sessions and longer duration improve outcomes 1
- Effective delivery methods include in-person, telephone quitlines, text messaging, and internet-based programs 1
- Counseling should include practical problem-solving skills, social support, and coping strategies for triggers 1
Combined Approach (Highest Success Rates)
Pharmacotherapy plus behavioral counseling achieves 15.2% quit rates at 6 months versus 8.6% with brief advice alone 2
The combination of comprehensive counseling plus pharmacotherapy can increase 6-month cessation rates from 6.8% to 21.3% 5
Treatment Algorithm
- Screen at every visit: Document tobacco use as a vital sign 4
- Advise firmly to quit using personalized, nonjudgmental language 1, 4
- Assess willingness to quit now 1, 4
- Prescribe varenicline (unless contraindicated) starting 1 week before quit date 1, 3, 2
- Provide or refer for behavioral counseling—minimum 4 sessions, telephone quitlines acceptable 1, 4
- Follow-up within 2-3 weeks to assess medication tolerability and smoking status 4
- Continue treatment for minimum 12 weeks, consider extending to 24 weeks for sustained abstinence 4, 3
Special Considerations
When Varenicline is Contraindicated or Not Tolerated
- Use combination NRT (patch + short-acting form) as next best option 1, 4
- Consider bupropion SR especially if depression is present 5
- Combining bupropion with NRT is superior to bupropion alone 1
Renal Impairment
- Severe renal impairment (CrCl <30 mL/min): varenicline 0.5 mg once daily, may titrate to 0.5 mg twice daily 3
- End-stage renal disease on hemodialysis: maximum 0.5 mg once daily 3
Relapse Management
- Relapse is common and expected—does not indicate need for different therapy 1
- Encourage repeated quit attempts with same effective therapy 1
- Identify and address factors contributing to relapse before next attempt 1
Common Pitfalls to Avoid
- Do not use varenicline with transdermal nicotine—high discontinuation rate due to adverse events 3
- Do not rely on pharmacotherapy alone—always combine with at least brief behavioral support 1
- Do not assume single brief advice is sufficient—arrange structured follow-up 1, 4
- Do not overlook documentation—record smoking status, interventions, and quit attempts at every visit 1